200 related articles for article (PubMed ID: 22385883)
1. Seasonal variations of systemic lupus erythematosus flares in southern France.
Chiche L; Jourde N; Ulmann C; Mancini J; Darque A; Bardin N; Dicostanzo MP; Thomas G; Harlé JR; Vienne J; Loukos H; Bornet C
Eur J Intern Med; 2012 Apr; 23(3):250-4. PubMed ID: 22385883
[TBL] [Abstract][Full Text] [Related]
2. Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong.
Szeto CC; Mok HY; Chow KM; Lee TC; Leung JY; Li EK; Tsui TK; Yu S; Tam LS
J Rheumatol; 2008 Jun; 35(6):1031-7. PubMed ID: 18398942
[TBL] [Abstract][Full Text] [Related]
3. Flares in pediatric systemic lupus erythematosus.
Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
[TBL] [Abstract][Full Text] [Related]
4. Seasonal variation of lupus nephritis in a cohort of Egyptian patients.
Abdelaziz TS; Rakha NK; Fayad T; Mahmoud GA; Fayed A; Hammad H
Clin Rheumatol; 2023 Apr; 42(4):1013-1018. PubMed ID: 36385599
[TBL] [Abstract][Full Text] [Related]
5. Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring.
Schlesinger N; Schlesinger M; Seshan SV
J Rheumatol; 2005 Jun; 32(6):1053-7. PubMed ID: 15940767
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
7. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
Petri M; Jones RJ; Brodsky RA
Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N
Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with active systemic lupus erythematosus after endstage renal disease.
Szeto CC; Li PK; Wong TY; Leung CB; Lui SF
J Rheumatol; 1998 Aug; 25(8):1520-5. PubMed ID: 9712094
[TBL] [Abstract][Full Text] [Related]
10. TULUP (TUnisian LUPus): a multicentric study of systemic lupus erythematosus in Tunisia.
Khanfir MS; Houman MH; Cherif E; Hamzaoui A; Souissi S; Ben Ghorbel I; Ksontini I; Braham A
Int J Rheum Dis; 2013 Oct; 16(5):539-46. PubMed ID: 24164841
[TBL] [Abstract][Full Text] [Related]
11. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
Ng KP; Manson JJ; Rahman A; Isenberg DA
Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
[TBL] [Abstract][Full Text] [Related]
12. Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis.
Parikh SV; Nagaraja HN; Hebert L; Rovin BH
Clin J Am Soc Nephrol; 2014 Feb; 9(2):279-84. PubMed ID: 24262502
[TBL] [Abstract][Full Text] [Related]
13. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[TBL] [Abstract][Full Text] [Related]
14. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.
Inês L; Duarte C; Silva RS; Teixeira AS; Fonseca FP; da Silva JA
Rheumatology (Oxford); 2014 Jan; 53(1):85-9. PubMed ID: 24067885
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study.
Petri M; Singh S; Tesfasyone H; Malik A
J Rheumatol; 2009 Nov; 36(11):2476-80. PubMed ID: 19833757
[TBL] [Abstract][Full Text] [Related]
16. Ovarian failure and flares of systemic lupus erythematosus.
Mok CC; Wong RW; Lau CS
Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
[TBL] [Abstract][Full Text] [Related]
17. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
[TBL] [Abstract][Full Text] [Related]
18. The impact of flare on disease costs of patients with systemic lupus erythematosus.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
20. Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine.
Mok CC; Ying KY; Yim CW; Ng WL; Wong WS
Lupus; 2009 Oct; 18(12):1091-5. PubMed ID: 19762384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]